← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Mississippi Medical Center
Jackson, MS
$83,192,765
Total funding
186
Grants
Funding over time
peak $14.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,357,552 · 119
DOD$10,144,252 · 31
NSF$3,745,763 · 16
USDA$1,653,647 · 12
DOE$742,743 · 3
NASA$548,807 · 2
AHRQ$0 · 2
CDC$0 · 1
By mechanism
R01$42,235,267 · 50
—$16,835,213 · 64
P01$7,663,927 · 9
N01$5,318,470 · 3
P20$3,477,591 · 26
U01$2,706,366 · 2
Investigators at University Of Mississippi Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
JACKSON HEART STUDY--EXAM CENTER$4,081,000
N01 · FY2000 · HC
Center for Research Excellence Psychiatric Neuroscience$2,277,039
P20 · FY2002 · RR
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL$2,182,210
P01 · FY2005 · HL
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL$2,118,638
P01 · FY2004 · HL
The ARIC and Neurocognitive Longitudinal Study$2,022,171
R01 · FY2003 · HL
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL$1,814,522
P01 · FY2003 · HL
Center for Research Excellence Psychiatric Neuroscience$1,789,193
P20 · FY2004 · RR
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL$1,765,956
P01 · FY2002 · HL
Center for Research Excellence Psychiatric Neuroscience$1,735,122
P20 · FY2003 · RR
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL$1,714,963
P01 · FY2001 · HL
The ARIC and Neurocognitive Longitudinal Study$1,697,872
R01 · FY2002 · HL
Center for Research Excellence Psychiatric Neuroscience$1,688,398
P20 · FY2005 · RR
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL$1,672,168
P01 · FY2000 · HL
SIGNALING INTERPLAY UNDERLYING PROSTATE CANCER RACIAL DISPARITY$1,386,000
· FY2025 · Defense Health Agency
The ARIC and Neurocognitive Longitudinal Study$1,351,906
R01 · FY2004 · HL
: IMPACT OF NICOTINE EXPOSURE ON PROSTATE CANCER PROGRESSION AND THERAPEUTIC OUTCOME$1,155,000
· FY2022 · Defense Health Agency
THE OVARIAN CANCER ACADEMY 2015-2020: A TEAM-BASED SCIENCE APPROACH$911,600
· FY2015 · Department of the Army
Leukocyte immune type receptors: gene structure and function$796,865
· FY2017 · BIO
ZEISS 880 CONFOCAL WITH AIRYSCAN TO STUDY AUDITORY/VESTIBULAR FUNCTION$771,196
· FY2018 · Department of the Navy
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** WHILE ONE-THIRD OF OUR FOOD DEPENDS ON POLLINATORS SUCH AS HONEYBEES, NEARLY 15% OF HONEYBEE COLONIES ARE LOST EVERY YEAR, SUGGESTING A PERSISTENT THREAT TO HONEYBEE HEALTH. THE VARROA MITES HAVE BEEN IDENTIFIED AS THE NUMBER ONE STRESSOR FOR HONEYBEE OPERATIONS AFFECTING OVER 40% OF THE COLONIES. IT IS STRIKING TO NOTE THAT THE USE OF PESTICIDES (INCLUDING THE CHEMICAL TREATMENTS USED TO CONTROL THE VARROA) AFFECT AN ADDITIONAL 5-10% OF HONEYBEE COLONIES. RESEARCH SHOWS THAT THE CURRENT METHODS OF MITE PREVENTION USING SYNTHETIC AS WELL AS NATURAL CHEMICALS ARE HAZARDOUS AND UNSAFE TO BOTH THE BEES AND BEEKEEPERS. TO IMPROVE HONEYBEE HEALTH, WE PROPOSE TO PREPARE NEW FORMULATIONS OF POLYMER-BASED MICROPARTICLES THAT ARE CAPABLE OF RELEASING THE ACTIVE MITICIDES INGREDIENTS IN A CONTROLLED MANNER OVER A LONGER PERIOD. OUR WORK IS DIVIDED INTO THREE SPECIFIC AIMS AS FOLLOWS. IN AIM 1, WE WILL SYNTHESIZE AND CHARACTERIZE MICROPARTICLES OF CONTROLLED SIZES USING TWO BIOCOMPATIBLE POLYMERS. IN AIM 2, WE WILL INCORPORATE VARIOUS MITICIDES INTO MICROPARTICLES AND STUDY THEIR RELEASE. IN AIM 3, WE WILL EVALUATE THE SAFETY OF MITICIDE-LOADED MICROPARTICLES BY EXPOSING THEM TO HUMAN CELLS AND HONEYBEES. WE WILL ALSO TEST THEIR EFFICACY AGAINST VARROA MITES IN SMALL-SCALE LABORATORY STUDIES AND IN REAL-LIFE BEEKEEPING CONDITIONS. THIS PROJECT WILL DEVELOP VASTLY MORE SOPHISTICATED POLYMER-BASED DRUG DELIVERY CARRIERS TO IMPROVE THE OVERALL EFFECTIVENESS OF MITICIDES IN HONEYBEE POPULATIONS. IF SUCCESSFUL, THIS NOVEL APPROACH FOR THE LONG-TERM TREATMENT OF HONEYBEES WILL SUBSTANTIALLY IMPROVE THE SURVIVABILITY OF INFECTED HIVES.$749,804
· FY2023 · National Institute of Food and Agriculture